G. Unal

Antiretroviral Therapy as Prevention of … Pneumococcal Infections?

F. Caron, O. Bouchaud, M. Etienne, 2016, Open Forum Infectious Diseases.

First report of transmission of a highly resistant strain of HIV-1 group O.

L. Meyer, J. Plantier, T. Mourez, 2016, AIDS.

Low Immune Response to Hepatitis B Vaccine among Children in Dakar, Senegal

A. Seck, D. Rousset, R. Njouom, 2012, PloS one.

Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O Variants

J. Plantier, M. Gueudin, E. Alessandri-Gradt, 2021, Journal of acquired immune deficiency syndromes.

HIV‐1 non‐group M phenotypic susceptibility to integrase strand transfer inhibitors

C. Charpentier, D. Descamps, J. Plantier, 2017, The Journal of antimicrobial chemotherapy.

Comparative immuno-virological and clinical responses to antiretroviral therapy between HIV-1 group O- and HIV-1 group M-infected patients (ANRS 12168 DynaMO study).

E. Delaporte, J. Dumortier, D. Rousset, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

C. Charpentier, C. Delaugerre, J. Pawlotsky, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of HIV-1 Group O Genetic Diversity on Genotypic Resistance Interpretation by Algorithms Designed for HIV-1 Group M

C. Charpentier, F. Damond, J. Plantier, 2011, Journal of acquired immune deficiency syndromes.

Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication

M. Cavassini, D. Bangsberg, M. Schneider, 2021, Open forum infectious diseases.

Virological response to integrase strand transfer inhibitor-based antiretroviral combinations in HIV-1 group O-infected patients.

J. Plantier, E. Alessandri-Gradt, G. Unal, 2019, AIDS.